https://orcid.org/0000-0002-6844-5642
References
- Tari K, Valizadeh Ardalan P, Abbaszadehdibavar M, et al. Thalassemia an update: molecular basis, clinical features and treatment. Int J Biomed Public Health. 2018;1(1):48–58.
- Galanello R, Origa R. β-thalassemia. Orphanet J Rare Dis. 2010;5:11.
- Kadhim KA, Baldawi KH, Lami FH. Prevalence, incidence, trend, and complications of thalassemia in Iraq. Hemoglobin. 2017;41(3):164–168.
- Olivieri NF. The β-thalassemias. N Engl J Med. 1999;341(2):99–109. Erratum: N Engl J Med. 1999;341(18):1407.
- Gardenghi S, Grady RW, Rivella S. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia. Hematol Oncol Clin North Am. 2010;24(6):1089–1107.
- Taher AT, Musallam KM, Karimi M, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2010;115(10):1886–1892.
- Leecharoenkiat K, Lithanatudom P, Sornjai W, et al. Iron dysregulation in β-thalassemia. Asian Pac J Trop Med. 2016;9(11):1035–1043.
- Park CH, Valore EV, Waring AJ, et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276(11):7806–7810.
- Papanikolaou G, Tzilianos M, Christakis JI, et al. Hepcidin in iron overload disorders. Blood. 2005;105(10):4103–4105.
- Makis A, Hatzimichael E, Papassotiriou I, et al. Clinical trials update in new treatments of β-thalassemia. Am J Hematol. 2016;91(11):1135–1145.
- Origa R, Galanello R, Ganz T, et al. Liver iron concentrations and urinary hepcidin in β-thalassemia. Haematologica. 2007;92(5):583–588.
- Haghpanah S, Esmaeilzadeh M, Honar N, et al. Relationship between serum hepcidin and ferritin levels in patients with thalassemia major and intermedia in Southern Iran. Iran Red Crescent Med J. 2015;17(5):e28343.
- Pasricha SR, Frazer DM, Bowden DK, et al. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study. Blood. 2013;122(1):124–133.
- Ismail NA, Habib SA, Talaat AA, et al. The relation between serum hepcidin, ferritin, hepcidin: ferritin ratio, hydroxyurea and splenectomy in children with β-thalassemia. Open Access Maced J Med Sci. 2019;7(15):2434–2439.
- Kaddah AM, Abdel-Salam A, Farhan MS, et al. Serum hepcidin as a diagnostic marker of severe iron overload in β-thalassemia major. Indian J Pediatr. 2017;84(10):745–750.
- Jones E, Pasricha S-R, Allen A, et al. Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait. Blood. 2015;125(5):873–880.
- El Beshlawy A, Alaraby I, Abdel Kader MSEM, et al. Study of serum hepcidin in hereditary hemolytic anemias. Hemoglobin. 2012;36(6):555–570.
- Valliere-Douglass JF, Brady LJ, Farnsworth C, et al. O-Fucosylation of an antibody light chain: characterization of a modification occurring on an IgG1 molecule. Glycobiology. 2009;19(2):144–152.
- Listinsky JJ, Siegal GP, Listinsky CM, et al. The emerging importance of α-L-fucose in human breast cancer: a review. Am J Transl Res. 2011;3(4):292–322.
- Becker DJ, Lowe JB. Fucose: biosynthesis and biological function in mammals. Glycobiology. 2003;13(7):41R–53R.
- Origa R, Cazzola M, Mereu E, et al. Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia. Haematologica. 2015;100(5):e169–e171.
- Dische Z, Shettles LB. A specific color reaction of methyl pentoses and a spectrophotometric micromethod for their determination. J Biol Chem. 1948;175(2):595–604.
- Winzler RJ. Determination of serum glycoproteins. Methods Biochem Anal. 1955;2:279–311.
- Assi MA. Estimation of α-L-fucose and vitamin D3 levels in β thalassemia patients in Al-Najaf Province. J Global Pharma Tech. 2019;11(5):192–195.